Repositorio Digital de la UPF
Publicación
Artículo científico (JournalArticle)
Proteome-wide model for human disease genetics
Missense variants remain a challenge in genetic interpretation owing to their subtle and context-dependent effects. Although current prediction models perform well in known disease genes, their scores are not calibrated across the proteome, limiting generalizability. To address this knowledge gap, we developed popEVE, a deep generative model combining evolutionary and human population data to estimate variant deleteriousness on a proteome-wide scale. popEVE achieves state-of-the-art performance without overestimating the burden of deleterious variants and identifies variants in 442 genes in a severe developmental disorder cohort, including 123 novel candidates. These genes are functionally similar to known disease genes, and their variants often localize to critical regions. Remarkably, popEVE can prioritize likely causal variants using only child exomes, enabling diagnosis even without parental sequencing. This work provides a generalizable framework for rare disease variant interpretation, especially in singleton cases, and demonstrates the utility of calibrated, evolution-informed scoring models for clinical genomics., We thank all members of the Marks Lab, Dias and Frazer Lab and Sander Lab for valuable discussions. We also thank J. Nicoludis and Invitae for their assistance with training some of the EVE models. R.O., A.W.K., C.A.S., M.D., J.F. and D.S.M. are supported by a Chan Zuckerberg Initiative Award (Neurodegeneration Challenge Network, CZI2018-191853). H.S. and D.S.M. are supported by a National Institutes of Health Transformational Research Award (TR01 1R01CA260415). C.A.S. is supported by the National Science Foundation Graduate Research Fellowship under grant no. DGE-2146755. M.D. and J.F. are supported by the Spanish Ministry of Science and Innovation (PID2022-140793NA-I00) funded by MCIN/AEI/10.13039/501100011033/FEDER, UE) and acknowledge the support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI /10.13039/501100011033) and the Generalitat de Catalunya through the CERCA programme.
Proyecto:
ES / 3PE PID2022-140793NA-I00